Centre moves to tighten controls on antibiotic manufacturing, bulk drug trade
The Centre plans to introduce stringent regulations on antibiotic manufacturing and distribution as a strategy to counteract antimicrobial resistance. Newly proposed measures require manufacturers to secure central approval for antimicrobial licenses, coupled with enhanced quality assessments. Wholesalers will also need distinct licenses for bulk drugs, promoting improved monitoring. Stakeholders are encouraged to provide public comments on these draft amendments prior…
Continue reading this story on The Times of India, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.